Search research articles
Contact Us
Filters
Showing results (11-20 of 137) with videos related to
Page
of 14
Sort By:
Gut
|
May 25, 2023
Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply
Adam S Faye, Tine Jess
Alimentary Pharmacology & Therapeutics
|
October 11, 2022
Letter: fighting the battle but losing the war-inflammatory bowel disease and venous thromboembolism. Authors' reply
Kate E Lee, Adam S Faye
Biometrics
|
July 20, 2019
A response-adaptive randomization procedure for multi-armed clinical trials with normally distributed outcomes
S Faye Williamson, Sofía S Villar
Annals of Clinical Biochemistry
|
March 1, 1987
Experience with the use of the Toxi-Lab TLC system in screening for morphine/heroin abuse
S Nadkarni, S Faye, A Hay
Alimentary Pharmacology & Therapeutics
|
May 10, 2022
Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes
Adam S Faye, Jordan E Axelrad
Gastroenterology
|
April 6, 2020
Age Is Just a Number-Frailty Associates With Outcomes of Patients With Inflammatory Bowel Disease
Adam S Faye, Jean-Frédéric Colombel
Alimentary Pharmacology & Therapeutics
|
November 4, 2024
Editorial: Disentangling Early-Life Antibiotics and Infections as Risk Factors for the Development of Childhood IBD
Katherine L Stone, Adam S Faye
Alimentary Pharmacology & Therapeutics
|
November 20, 2025
Editorial: Remission Ambition-How Far Should We Push in Older Adults? Authors' Reply
Catherine Z Tang, Adam S Faye
Alimentary Pharmacology & Therapeutics
|
September 7, 2022
Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA-authors' reply
Kate E Lee, Adam S Faye
Inflammatory Bowel Diseases
|
April 27, 2021
Aging and IBD: A New Challenge for Clinicians and Researchers
Adam S Faye, Jean-Frederic Colombel
Page
of 14
Search research articles
Search
Showing results (11-20 of 137) with videos related to
Sort By:
Page
of 14
Gut
|
May 25, 2023
Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply
Adam S Faye, Tine Jess
Alimentary Pharmacology & Therapeutics
|
October 11, 2022
Letter: fighting the battle but losing the war-inflammatory bowel disease and venous thromboembolism. Authors' reply
Kate E Lee, Adam S Faye
Biometrics
|
July 20, 2019
A response-adaptive randomization procedure for multi-armed clinical trials with normally distributed outcomes
S Faye Williamson, Sofía S Villar
Annals of Clinical Biochemistry
|
March 1, 1987
Experience with the use of the Toxi-Lab TLC system in screening for morphine/heroin abuse
S Nadkarni, S Faye, A Hay
Alimentary Pharmacology & Therapeutics
|
May 10, 2022
Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes
Adam S Faye, Jordan E Axelrad
Gastroenterology
|
April 6, 2020
Age Is Just a Number-Frailty Associates With Outcomes of Patients With Inflammatory Bowel Disease
Adam S Faye, Jean-Frédéric Colombel
Alimentary Pharmacology & Therapeutics
|
November 4, 2024
Editorial: Disentangling Early-Life Antibiotics and Infections as Risk Factors for the Development of Childhood IBD
Katherine L Stone, Adam S Faye
Alimentary Pharmacology & Therapeutics
|
November 20, 2025
Editorial: Remission Ambition-How Far Should We Push in Older Adults? Authors' Reply
Catherine Z Tang, Adam S Faye
Alimentary Pharmacology & Therapeutics
|
September 7, 2022
Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA-authors' reply
Kate E Lee, Adam S Faye
Inflammatory Bowel Diseases
|
April 27, 2021
Aging and IBD: A New Challenge for Clinicians and Researchers
Adam S Faye, Jean-Frederic Colombel
Page
of 14